These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 32061771)

  • 1. NOSH-aspirin (NBS-1120) inhibits pancreatic cancer cell growth in a xenograft mouse model: Modulation of FoxM1, p53, NF-κB, iNOS, caspase-3 and ROS.
    Chattopadhyay M; Kodela R; Santiago G; Le TTC; Nath N; Kashfi K
    Biochem Pharmacol; 2020 Jun; 176():113857. PubMed ID: 32061771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NOSH-aspirin (NBS-1120), a novel nitric oxide- and hydrogen sulfide-releasing hybrid is a potent inhibitor of colon cancer cell growth in vitro and in a xenograft mouse model.
    Chattopadhyay M; Kodela R; Olson KR; Kashfi K
    Biochem Biophys Res Commun; 2012 Mar; 419(3):523-8. PubMed ID: 22366248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility Of Nitric Oxide And Hydrogen Sulfide-Releasing Chimeras As Anticancer Agents.
    Kashfi K
    Redox Biol; 2015 Aug; 5():420. PubMed ID: 28162289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NOSH-aspirin (NBS-1120) inhibits estrogen receptor negative breast cancer
    Chattopadhyay M; Nath N; Kodela R; Metkar S; Soyemi SA; Kashfi K
    J Pharmacol Exp Ther; 2024 Jun; ():. PubMed ID: 38936976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and anti-cancer potential of the positional isomers of NOSH-aspirin (NBS-1120) a dual nitric oxide and hydrogen sulfide releasing hybrid.
    Vannini F; MacKessack-Leitch AC; Eschbach EK; Chattopadhyay M; Kodela R; Kashfi K
    Bioorg Med Chem Lett; 2015 Oct; 25(20):4677-82. PubMed ID: 26323873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positional isomerism markedly affects the growth inhibition of colon cancer cells by NOSH-aspirin: COX inhibition and modeling.
    Vannini F; Chattopadhyay M; Kodela R; Rao PPN; Kashfi K
    Redox Biol; 2015 Dec; 6():318-325. PubMed ID: 26319435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NOSH-Aspirin Inhibits Colon Cancer Cell Growth: Effects Of Positional Isomerism.
    Vannini F; Kodela R; Chattopadhyay M; Kashfi K
    Redox Biol; 2015 Aug; 5():421. PubMed ID: 28162291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nitric Oxide-Releasing Aspirin Suppresses NF-κB Signaling in Estrogen Receptor Negative Breast Cancer Cells in Vitro and in Vivo.
    Nath N; Chattopadhyay M; Rodes DB; Nazarenko A; Kodela R; Kashfi K
    Molecules; 2015 Jul; 20(7):12481-99. PubMed ID: 26184135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NOSH-aspirin (NBS-1120), a novel nitric oxide- and hydrogen sulfide-releasing hybrid has enhanced chemo-preventive properties compared to aspirin, is gastrointestinal safe with all the classic therapeutic indications.
    Kodela R; Chattopadhyay M; Velázquez-Martínez CA; Kashfi K
    Biochem Pharmacol; 2015 Dec; 98(4):564-72. PubMed ID: 26394025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NOSH-aspirin (NBS-1120), a novel nitric oxide and hydrogen sulfide releasing hybrid, attenuates neuroinflammation induced by microglial and astrocytic activation: a new candidate for treatment of neurodegenerative disorders.
    Lee M; McGeer E; Kodela R; Kashfi K; McGeer PL
    Glia; 2013 Oct; 61(10):1724-34. PubMed ID: 23918470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydrogen sulfide-releasing aspirin suppresses NF-κB signaling in estrogen receptor negative breast cancer cells in vitro and in vivo.
    Chattopadhyay M; Kodela R; Nath N; Barsegian A; Boring D; Kashfi K
    Biochem Pharmacol; 2012 Mar; 83(6):723-32. PubMed ID: 22209867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bufalin inhibits pancreatic cancer by inducing cell cycle arrest via the c-Myc/NF-κB pathway.
    Liu X; Xiao XY; Shou QY; Yan JF; Chen L; Fu HY; Wang JC
    J Ethnopharmacol; 2016 Dec; 193():538-545. PubMed ID: 27686271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydrogen sulfide-releasing naproxen suppresses colon cancer cell growth and inhibits NF-κB signaling.
    Kodela R; Nath N; Chattopadhyay M; Nesbitt DE; Velázquez-Martínez CA; Kashfi K
    Drug Des Devel Ther; 2015; 9():4873-82. PubMed ID: 26346117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pseudomonas aeruginosa-mannose-sensitive hemagglutinin inhibits pancreatic cancer cell proliferation and induces apoptosis via the EGFR pathway and caspase signaling.
    Cheng X; Wang B; Jin Z; Ma D; Yang W; Zhao R; Jing X; Shen B; Peng C; Qiu W
    Oncotarget; 2016 Nov; 7(47):77916-77925. PubMed ID: 27788491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring the Potential of Nitric Oxide and Hydrogen Sulfide (NOSH)-Releasing Synthetic Compounds as Novel Priming Agents against Drought Stress in
    Antoniou C; Xenofontos R; Chatzimichail G; Christou A; Kashfi K; Fotopoulos V
    Biomolecules; 2020 Jan; 10(1):. PubMed ID: 31936819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ellagic acid inhibits the proliferation of human pancreatic carcinoma PANC-1 cells in vitro and in vivo.
    Cheng H; Lu C; Tang R; Pan Y; Bao S; Qiu Y; Xie M
    Oncotarget; 2017 Feb; 8(7):12301-12310. PubMed ID: 28135203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Boswellic acid suppresses growth and metastasis of human pancreatic tumors in an orthotopic nude mouse model through modulation of multiple targets.
    Park B; Prasad S; Yadav V; Sung B; Aggarwal BB
    PLoS One; 2011; 6(10):e26943. PubMed ID: 22066019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel natural product, britanin, inhibits tumor growth of pancreatic cancer by suppressing nuclear factor-κB activation.
    Li K; Zhou Y; Chen Y; Zhou L; Liang J
    Cancer Chemother Pharmacol; 2020 Apr; 85(4):699-709. PubMed ID: 32185482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NOSH-sulindac (AVT-18A) is a novel nitric oxide- and hydrogen sulfide-releasing hybrid that is gastrointestinal safe and has potent anti-inflammatory, analgesic, antipyretic, anti-platelet, and anti-cancer properties.
    Kashfi K; Chattopadhyay M; Kodela R
    Redox Biol; 2015 Dec; 6():287-296. PubMed ID: 26298203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genistein induced anticancer effects on pancreatic cancer cell lines involves mitochondrial apoptosis, G
    Bi YL; Min M; Shen W; Liu Y
    Phytomedicine; 2018 Jan; 39():10-16. PubMed ID: 29433670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.